Cargando…
Beyond pigmentation: signs of liver protection during afamelanotide treatment in Swiss patients with erythropoietic protoporphyria, an observational study
Erythropoietic protoporphyria (EPP) is an ultra-rare inherited disorder with overproduction of protoporphyrin in maturating erythroblasts. This excess protoporphyrin leads to incapacitating phototoxic burns in sunlight exposed skin. Its biliary elimination causes cholestatic liver injury in 20% and...
Autores principales: | Minder, Anna-Elisabeth, Barman-Aksoezen, Jasmin, Schmid, Mathias, Minder, Elisabeth I., Zulewski, Henryk, Minder, Christoph E., Schneider-Yin, Xiaoye |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10032460/ https://www.ncbi.nlm.nih.gov/pubmed/37181106 http://dx.doi.org/10.1177/26330040211065453 |
Ejemplares similares
-
Afamelanotide Is Associated with Dose-Dependent Protective Effect from Liver Damage Related to Erythropoietic Protoporphyria
por: Minder, Anna-Elisabeth, et al.
Publicado: (2023) -
Increased phototoxic burn tolerance time and quality of life in patients with erythropoietic protoporphyria treated with afamelanotide – a three years observational study
por: Barman-Aksözen, Jasmin, et al.
Publicado: (2020) -
Advances in the management of erythropoietic protoporphyria – role of afamelanotide
por: Lane, Ashley M, et al.
Publicado: (2016) -
Modeling the ferrochelatase c.315-48C modifier mutation for erythropoietic protoporphyria (EPP) in mice
por: Barman-Aksözen, Jasmin, et al.
Publicado: (2017) -
Patient-recorded outcome to assess therapeutic efficacy in protoporphyria-induced dermal phototoxicity: a proposal
por: Minder, Elisabeth I, et al.
Publicado: (2010)